News Releases News Releases Year None2020201920182016 May, 26 2020 TransMedics Announces Pricing of Public Offering of Common Stock May, 26 2020 TransMedics Announces Proposed Public Offering of Common Stock May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial May, 6 2020 TransMedics Reports First Quarter 2020 Financial Results Apr, 23 2020 TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020 Apr, 13 2020 TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020 Mar, 17 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency Mar, 2 2020 TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results Feb, 20 2020 TransMedics to Present at the Cowen 40th Annual Health Care Conference Feb, 19 2020 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020
News Releases Year None2020201920182016 May, 26 2020 TransMedics Announces Pricing of Public Offering of Common Stock May, 26 2020 TransMedics Announces Proposed Public Offering of Common Stock May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial May, 6 2020 TransMedics Reports First Quarter 2020 Financial Results Apr, 23 2020 TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020 Apr, 13 2020 TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020 Mar, 17 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency Mar, 2 2020 TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results Feb, 20 2020 TransMedics to Present at the Cowen 40th Annual Health Care Conference Feb, 19 2020 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020
May, 26 2020 TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial
Apr, 13 2020 TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020
Mar, 17 2020 TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency
Feb, 19 2020 TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020
